This inventor holds 4 USPTO granted patents and 2 published patent applications. Top assignee: Regenxbio Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Devin Mcdougald and Microdystrophin Gene Therapy Patents
Introduction
Devin Mcdougald is an inventor associated with Regenxbio Inc. and located in Boston, Massachusetts. The provided information credits him with 4 patents.
Latest Patents
His latest patent titles include “Microdystrophin Nucleic Acid Gene Therapy Constructs and Uses Thereof” and “Methods of Manufacturing Microdystrophin Gene Therapy Constructs.” These titles concern gene therapy constructs and methods for manufacturing them.
Career Highlights
Mcdougald’s listed patent work is associated with Regenxbio Inc., a company involved in biotechnology and gene therapy research.
Collaborations
The provided information identifies Ye Liu and Olivier Danos as some of Mcdougald’s coworkers.
Conclusion
Devin Mcdougald’s listed inventions focus on microdystrophin gene therapy constructs and their manufacture, reflecting his patent-related work with Regenxbio Inc.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile